Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland

Environmental Health Perspectives

Volumn 107, Issue 9, 1999, Pages 705-710

  Kurttio, Päivi ^a   Pukkala, Eero ^b   Kahelin, Hanna ^c   Auvinen, Anssi ^d   Pekkanen, Juha ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b FINNISH CANCER REGISTRY   (Finland)

^c GEOLOGICAL SURVEY OF FINLAND   (Finland)

^d STUK RADIATION AND NUCLEAR SAFETY AUTHORITY   (Finland)

Author keywords

Arsenic; Bladder cancer; Drinking water; Kidney cancer; Rural; Urinary organ cancers; Well water

Indexed keywords

ARSENIC; WELL WATER;

ARTICLE; BLADDER CANCER; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; FINLAND; HUMAN; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; WATER SAMPLING;

EID: 0032878755     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.99107705     Document Type: Article

References (41)

1. IARC. Arsenic and arsenic compounds. IARC Monogr Eval Carcinog Risk Chem Hum 23:39-141 (1980).
2. Kliment V. Model of multiple exposure to contaminants in monitoring the environmental impact on population health. Cant Eur J Public Health 4:246-249 (1996).
3. Smith AH, Hopenhayn-Rich C, Bates MN, Goeden HM, Hertz-Picciotto I, Duggan HM, Wood R, Kosnett MJ, Smith MT. Cancer risks from arsenic in drinking water. Environ Health Perspect 97:259-267 (1992).
4. WHO. Guidelines for Drinking-Water Quality. 2nd ed. Geneva:World Health Organization International Programme on Chemical Safety, 1996;156-167.
5. Tseng W-P. Effects and dose-response relationships of skin cancer and Blackfoot disease with arsenic. Environ Health Perspect 19:109-119 (1977).
6. Chen C-J, Kuo TL, Wu M. Arsenic and cancers. Lancet 1:414-415 (1988).
7. Chen C-J, Chen CW, Wu M-M, Kuo T-L Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br J Cancer 66:888-892 (1992).
8. Wu MM, Kuo TL, Hwang Y, Chen C. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol 130:1123-1132 (1989).
9. Chiou HY, Hsueh YM, Liaw KF, Horng SF, Chiang MH, Pa YS, Lin JS, Huang CH, Chen CJ. Incidence of internal cancers and ingested inorganic arsenic: a seven-year followup study in Taiwan. Cancer Res 55:1296-1300 (1995).
10. Chen C-J, Wang CJ. Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms. Cancer Res 50:5470-5474 (1990).
11. Guo H-R, Chiang H-S, Hu H, Lipsitz SR, Monson RR. Arsenic in drinking water and incidence of urinary cancers. Epidemiology 8:545-550 (1997).
12. Hopenhayn-Rich C, Biggs ML, Fuchs A, Bergoglio R, Tello EE, Nicolli H, Smith AH. Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology 7:117-124 (1996).
13. Hopenhayn-Rich C, Biggs ML, Smith AH. Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba, Argentina. Im J Epidemiol 27:561-569 (1993).
14. Tsuda T, Nagira T, Yamamoto M, Kume Y. An epidemiological study on cancer in certified arsenic poisoning patients in Toruku. Ind Health 28:53-62 (1990).
15. Tsuda T, Babazono A, Yamamoto E, Kurumatani N, Mino Y, Ogawa T, Kishi Y, Aoyama H. Ingested arsenic and internal cancer: a historical cohort study followed for 33 years. Am J Epidemiol 141:198-209 (1995).
16. Smith AH, Goycolea M, Hague R, Biggs ML. Marked increase in bladder and lung cancer mortality in a region of northern Chile due to arsenic in drinking water. Am J Epidemiol 147:660-669 (1998).
17. Bates MN, Smith AH, Cantor KP. Case-control study of bladder cancer and arsenic in drinking water. Am J Epidemiol 111:523-530 (1995).
18. Kujala-Räty K, Hiisvirta L, Kaukonen M, Liponkoski M, Sipilä A. Quality of Household Water in Finland in 1996 [in Finnish]. Finnish Environment 181. Helsinki:Edita Ltd, 1998.
19. Kurttio P, Komulainen H, Hakala E, Kahelin H, Pekkanen J. Urinary excretion of arsenic species after exposure to arsenic present in drinking water. Arch Environ Contem Toxicol 34:297-305 (1998).
20. Lahermo P, Väänänen P, Tarvainen T, Salminen R. Geochemical Atlas of Finland, Part 3: Environmental Geochemistry - stream waters and sediments [in Finnish]. Espoo, Finland:Geological Survey of Finland, 1996.
21. Prentice RL. A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika 73:1-11 (1986).
22. Lahermo P, Alfthan G, Wang D. Selenium and arsenic in the environment in Finland. J Environ Pathol Toxicol Oncol 17:205-216 (1998).
23. Barlow WE. Robust variance estimation of case-cohort design. Biometrics 50:1064-1072 (1994).
24. Dreyer L, Winther JF, Pukkala E, Andersen A. Tobacco smoking. APMIS Suppl.76:9-47 (1997).
25. McLaughlin JK, Blot WJ, Devesa SS, Fraumeni JF Jr. Renal cancer. In: Cancer Epidemiology and Prevention (Schottenfeld D, Fraumeni JF Jr, eds). New York:Oxford University Press, 1996;1142-1155.
26. Muscat JE, Hoffmann D, Wynder EL. The epidemiology of renal cell carcinoma: a second look. Cancer 75:2552-2557 (1995).
27. Valberg PA, Beck BD, Bowers TS, Keating JL, Bergstrom PD, Boardman PD. Issues in setting health-based cleanup levels for arsenic in soil. Reg Toxicol Pharmacol 26:219-229 (1997).
28. Tseng WP, Chu HM, How S, Fong J, Lin C, Yeh S. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J Natl Cancer Inst 40:453-463 (1968).
29. Cuzick J, Sasieni P, Evans S. Ingested arsenic, karatoses and bladder cancer. Am J Epidemiol 136:417-421 (1992).
30. Brown JL, Kitchin KT. Arsenite, but not cadmium, induces ornithine decarboxylase and heme oxygenase activity in rat liver: relevance to arsenic carcinogenesis. Cancer Lett 98:227-231 (1996).
31. Mass MJ, Wang L. Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis. Mutat Res 386:263-277 (1997).
32. Li JH, Rossman TG. Mechanism of comutagenesis of sodium arsenite with n-methyl-n-nitrosourea. Biol Trace Elem Res 21:373-381 (1989).
33. Wang TC, Huang JS, Yang VC, Lan HJ, Lin CJ, Jan KY. Delay of the excision of UV light-induced DNA adducts is involved in the coclastogenicity of UV light plus arsenite. Int J Radiat Biol 66:367-372 (1994).
34. Schrauzer GN. Selenium. Mechanistic aspects of anticarcinogenic action. Biol Trace Element Res 33:51-62 (1992).
35. Berry JP, Galle P. Selenium-arsenic interaction in renal cells: role of lysosomes. Electron microprobe study. J Submicrosc Cytol Pathol 26:203-210 (1994).
36. Styblo M, Delnomdedieu M, Thomas DJ. Mono-and dimethylation of arsenic in rat liver cytosol in vitro. Chem-Biol Interact 99:147-164 (1996).
37. Varo P, Koivistoinen P. XII. Mineral element composition of Finnish foods. Acta Agric Scand Suppl 22:165-171 (1980).
38. National Public Health Institute. Expert Group on Nutritional Follow-up, Report on Nutrition 1995 [in Finnish]. National Public Health Institute B1/1996. Helsinki:National Public Health Institute, 1996.
39. Boyle CA, Brann EA. Proxy respondents and the validity of occupational and other exposure data. The Selected Cancers Cooperative Study Group. Am J Epidemiol 136:712-721 (1992).
40. Lyon JL, Egger MJ, Robison LM, French TK, Gao R. Misclassification of exposure in a case-control study: the effects of different types of exposure and different proxy respondents in e study of pancreatic cancer. Epidemiology 3:223-231 (1992).
41. Nelson LM, Longstreth WT Jr, Koepsell TD, Checkoway H, van Belle G. Completeness and accuracy of interview data from proxy respondents: demographic, medical, and life-style factors. Epidemiology 5:204-217 (1994).